Researcher biography

With her experience in cell biology, biochemistry, proteomics and mass spectrometry, Associate Professor Michelle Hill is leading her team in two areas of translational cancer research. The clinical diagnostics team aims to develop new clinical tests for the management of cancer, including early detection, prognosis and personalized therapy selection. The cancer mechanisms team is dissecting the link between metabolism (obesity) and cancer, with current focus on the role of cholesterol-rich membrane microdomains in cancer spreading (metastasis).

A/Prof Hill obtained her PhD investigating insulin signalling using phosphoproteomics with Prof David James at the University of Queensland. She undertook two postdoctoral positions in Switzerland (Dr Brian Hemmings) and Ireland (Prof Seamus Martin) before returning Brisbane where she worked with Prof Rob Parton and Prof John Hancock on signalling from lipid rafts and caveolae. In 2009, Michelle established the Cancer Proteomics Group at UQ Diamantina Institute, Princess Alexandra Hospital, supported by an National Health and Medical Research Council Career Development Fellowship. Her novel approach to understanding cellular lipid raft function was recognised by award of a prestigious Australian Research Council Future Fellowship in 2012.

A/Prof Hill is an elected member of the international Human Proteome Organisation (HUPO) Council (2016-2018) and recently completed her service on the Australasian Proteomics Society Executive Committee.